Shares of Hikma Pharmaceuticals PLC HIK rallied 1.64% to £18.01 Thursday, on what proved to be an all-around poor trading ...

The company also reiterated guidance for its Branded business of revenue in the high-single digits, or 6% to 8% higher year-on-year, with a core operating margin around 25%. Its Generics business is ...

FMI’s latest analysis underscores a remarkable surge in demand for pharmaceutical products within the Kingdom, with market value expected to exceed USD 10,113.1 million by 2024. This impressive growth ...

Analyst Christian Glennie from Stifel Nicolaus reiterated a Buy rating on Hikma Pharmaceuticals (HIK – Research Report) and keeping the ...

Set up in 2009, Cloud aims to use its technology to accelerate the drug discovery and design process by using a proprietary AI-driven process to deliver novel molecules tailored to a drug target ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Graduates of this course have gone on to work with organisations such as the National Health Service (NHS), King Faisal University, Hikma Pharmaceuticals and Thermo ... and cellular pharmacology and ...

On our product design courses, you’ll work on live briefs, creating functional and tangible designs with industry-standard equipment and software. Based in the School of Architecture, Design, and the ...